Q4 2023 VolitionRX Ltd Earnings Call Transcript
Good morning, ladies and gentlemen, and thank you for standing by and welcome to VolitionRx Limited Fourth Quarter and Full Year 2023 earnings conference call. (Operator Instructions) This conference call is being recorded today March 26th, 2024.
I would now like to turn the conference over to Louise Batchelor, Group Chief Marketing and Communications Officer. Please go ahead.
Thank you, and welcome, everyone to today's analyst conference call for Volition Rx Limited. Before we begin, I'd like to remind everyone that some of the information discussed on this conference call will include forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our beliefs as well as assumptions we have used based upon information currently available to us Because these statements reflect our current views concerning future events. These statements involve risks, uncertainties and assumptions.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |